ZAS Middelheim
Antwerp 2020
4 studies enrolling now · 5 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Heart Failure, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
Studies at this site
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- Alleviant ALLAY-HFrEF Study — Enrolling by invitation
- Alleviant ALLAY-HF Study — Enrolling by invitation